ADVITOS

Germany
Munich, Bavaria, Germany, 80992

Company profile

ADVITOS company profile

ADVOS is the world’s first method for the combined multi-organ support of liver, lung, kidney, and acid-base balance. Based on the principle of albumin dialysis, ADVOS allows extracorporeal fluid-based elimination of CO2, hepatic toxins, water-soluble and protein-bound nephrotoxins, as well as the correction of metabolic and respiratory acidosis. The ADVOS method works with typical dialysis accesses and flow rates and does not require any gas exchangers for CO2 elimination.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
80992
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$24.3M
Last funding
Series Unknown / $24.3M / 2021-06-10
Last equity funding
Series Unknown / $24.3M
Investors
2
Lead investors
2
Founders
1
Articles
6

Founders and investors

Founders

Bernhard Kreymann

Lead investors

Crédit Mutuel InnovationEuropean Innovation Council

Investors

Crédit Mutuel InnovationEuropean Innovation Council